Literature DB >> 22847331

Cross-presentation of IgG-containing immune complexes.

Kristi Baker1, Timo Rath, Wayne I Lencer, Edda Fiebiger, Richard S Blumberg.   

Abstract

IgG is a molecule that functionally combines facets of both innate and adaptive immunity and therefore bridges both arms of the immune system. On the one hand, IgG is created by adaptive immune cells, but can be generated by B cells independently of T cell help. On the other hand, once secreted, IgG can rapidly deliver antigens into intracellular processing pathways, which enable efficient priming of T cell responses towards epitopes from the cognate antigen initially bound by the IgG. While this process has long been known to participate in CD4(+) T cell activation, IgG-mediated delivery of exogenous antigens into a major histocompatibility complex (MHC) class I processing pathway has received less attention. The coordinated engagement of IgG with IgG receptors expressed on the cell-surface (FcγR) and within the endolysosomal system (FcRn) is a highly potent means to deliver antigen into processing pathways that promote cross-presentation of MHC class I and presentation of MHC class II-restricted epitopes within the same dendritic cell. This review focuses on the mechanisms by which IgG-containing immune complexes mediate such cross-presentation and the implications that this understanding has for manipulation of immune-mediated diseases that depend upon or are due to the activities of CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847331      PMCID: PMC3609906          DOI: 10.1007/s00018-012-1100-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  183 in total

1.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding.

Authors:  W L Martin; A P West; L Gan; P J Bjorkman
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

2.  Phagosomes are competent organelles for antigen cross-presentation.

Authors:  Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

3.  The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.

Authors:  Sven Burgdorf; Veronika Lukacs-Kornek; Christian Kurts
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

Authors:  Juliette Mouriès; Gabriel Moron; Géraldine Schlecht; Nicolas Escriou; Gilles Dadaglio; Claude Leclerc
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

5.  The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.

Authors:  Xindong Liu; Li Lu; Ziyan Yang; Senthilkumar Palaniyandi; Rongyu Zeng; Lian-Yong Gao; David M Mosser; Derry C Roopenian; Xiaoping Zhu
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

6.  The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans.

Authors:  M Firan; R Bawdon; C Radu; R J Ober; D Eaken; F Antohe; V Ghetie; E S Ward
Journal:  Int Immunol       Date:  2001-08       Impact factor: 4.823

7.  An Fc receptor structurally related to MHC class I antigens.

Authors:  N E Simister; K E Mostov
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

8.  Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy T Kuo; Victoria G Aveson; Barbara Platzer; Jan-Terje Andersen; Inger Sandlie; Zhangguo Chen; Colin de Haar; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

9.  Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation.

Authors:  Matthias Zehner; Achmet Imam Chasan; Verena Schuette; Maria Embgenbroich; Thomas Quast; Waldemar Kolanus; Sven Burgdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

10.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  18 in total

1.  Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody.

Authors:  Shui-On Leung; Kai Gao; Guang Yu Wang; Benny Ka-Wa Cheung; Kwan-Yeung Lee; Qi Zhao; Wing-Tai Cheung; Jun Zhi Wang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.

Authors:  Carylinda Serna; Joshua A Lara; Silas P Rodrigues; Alexandre F Marques; Igor C Almeida; Rosa A Maldonado
Journal:  Vaccine       Date:  2014-04-30       Impact factor: 3.641

Review 3.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

Review 4.  Targeting FcRn to Generate Antibody-Based Therapeutics.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Trends Pharmacol Sci       Date:  2018-08-22       Impact factor: 14.819

Review 5.  Neonatal Fc Receptor-Targeted Therapies in Neurology.

Authors:  Christopher Nelke; Marianna Spatola; Christina B Schroeter; Heinz Wiendl; Jan D Lünemann
Journal:  Neurotherapeutics       Date:  2022-01-07       Impact factor: 6.088

6.  FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes.

Authors:  Arjan van der Flier; Zhan Liu; Siyuan Tan; Kai Chen; Douglas Drager; Tongyao Liu; Susannah Patarroyo-White; Haiyan Jiang; David R Light
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

Review 7.  Regulation of immune responses by the neonatal fc receptor and its therapeutic implications.

Authors:  Timo Rath; Kristi Baker; Michal Pyzik; Richard S Blumberg
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

Review 8.  Autophagy-associated immune responses and cancer immunotherapy.

Authors:  Hongming Pan; Liuxi Chen; Yinghua Xu; Weidong Han; Fang Lou; Weiqiang Fei; Shuiping Liu; Zhao Jing; Xinbing Sui
Journal:  Oncotarget       Date:  2016-04-19

Review 9.  Antigen cross-presentation of immune complexes.

Authors:  Barbara Platzer; Madeleine Stout; Edda Fiebiger
Journal:  Front Immunol       Date:  2014-04-01       Impact factor: 7.561

10.  Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.

Authors:  Beatriz León; André Ballesteros-Tato; Troy D Randall; Frances E Lund
Journal:  J Exp Med       Date:  2014-07-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.